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Investigating subcellular localization of tPA and PAI-1 in the mammalian circadian clock 
Tucker Hunley 
ABSTRACT 
Mammalian circadian rhythms are controlled by a central pacemaker located in the 
suprachiasmatic nucleus (SCN) of the brain. The SCN exhibits endogenous rhythms in neuronal 
activity and entrains to external stimuli, particularly light. Interestingly, phase shifts in response 
to light only occur at night and the mechanisms gating phase shifting are not well characterized. 
Our lab demonstrated that the extracellular protease, tissue-type plasminogen activator (tPA) and 
its inhibitor, plasminogen activator inhibitor-1 (PAI-1), help gate phase shifting. Total tPA and 
PAI-1 expression are rhythmic in mouse SCN.  These proteins mediate different functions 
depending on their exact subcellular localization. Therefore, knowing where they are located 
within the SCN will clarify their actions with respect to SCN clock phase regulation. The 
immortalized rat SCN2.2 cell culture exhibits rhythms in protein expression in vitro that mirror 
those found in vivo and can be separated into cellular, extracellular matrix, and media fractions.  
Here, we investigate tPA and PAI-1 expression using western blotting in the cellular fraction of 
the SCN2.2 line over a 36-hour timecourse. Preliminary results suggest a rhythm of PAI-1 levels 
inside the cell with peak expression in the early subjective night while tPA levels possibly 
increase continuously. Future studies are aimed toward elucidating the subcellular localization 




Circadian rhythms are daily 24-hour cycles of arousal and rest, as well as a multitude of 
other physiological cycles, exhibited by a vast number of organisms. These oscillations manifest 
Hunley 3 
 
themselves in multiple ways with examples ranging from changes in gene transcription of 
chlorophyll in pea plants to the triple Kai protein clock system in cyanobacteria to melatonin 
regulation and synchronization of peripheral tissue subordinate clocks in mice (Foster, 2005, 
Johnson, 2007, Peek et al., 2015). Few topics in biology are as ubiquitous between species and as 
vital to the function and survival of each organism as the circadian rhythm. 
This study focuses on the mammalian circadian clock located in an area of the 
hypothalamus called the suprachiasmatic nucleus (SCN), named so because of its position 
superior to the optic chiasm. Behaviors such as wakefulness, glucose metabolism, and sleep, 
among other physiological functions, are all dependent on the SCN’s rhythmic control and the 
body’s current stage within the cycle (Peek et al., 2015). This brain region serves two main 
functions: continuously maintain the roughly 24-hour cadence of the internal circadian clock and 
be able to adapt to external light stimuli in order to synchronize the animal’s circadian rhythm to 
the environment. Because of the SCN’s ability to maintain and shift this daily pattern, the brain 
region is often referred to as the master pacemaker. 
The endogenous clock characteristics were discovered when experiments were performed 
on animals placed into constant light or constant dark environments (Halberg, 1959). Despite not 
being able to detect the time of day based on presence or absence of light, the subjects still 
maintained a roughly 24-hour cycle of rest and activity. This observation can be described as the 
free running period which describes any situation where an animal’s endogenous rhythm can 
cycle at its preferred rate without the influence of the environment. The SCN can endogenously 
maintain this free-running period through transcription/translation loops of clock genes that 




The second characteristic is the SCN’s ability to adapt to the environment and shift the 
phase, but not the duration, of the circadian rhythm. From its functionally relevant location, the 
SCN receives input signals from the eye via the retinohypothalamic tract (RHT) whenever light 
is detected. Light either advances or delays the phase depending whether the stimulus is 
presented in the late or early night, respectively (Daan et al., 1976). Although not exclusive, light 
is the most influential zeitgeber, German for “time giver,” that entrains the circadian clock. This 
allows the animal to adjust its rhythm to seasonal changes in day length or feeding and activity 
patterns. 
This study is focused on the second function of the SCN: phase shifting. Upon 
stimulation of the retina by light, axon terminals of the RHT release the neurotransmitter, 
glutamate, onto SCN neurons. If this occurs during the subjective night time, the SCN will shift 
in phase (Ebling, 1996). Through experimentation, it has been observed that providing glutamate 
to SCN containing brain slices during the early subjective night will cause a delay of up to 3 
hours in the circadian clock. In contrast, exposing the SCN to glutamate during the late 
subjective night will advance the clock by up to 3 hours (Ding et al., 1994). The stimulus 
necessary to produce glutamate, light, is present all day yet the SCN cannot shift its rhythm 
during the day. 
Our lab investigates the mechanisms controlling phase shifts and those that gate the 
ability of the clock to shift. Light induced glutamate transmission to the SCN activates NMDA 
receptors as seen in Figure 1. Activation of these receptors leads to calcium ion influx into the 
post-synaptic SCN neuron and subsequent activation of nitric oxide synthase, which both 
contribute to resetting the transcription and translation loop of clock genes (Ding et al., 1994). 
These glutamate induced shifts depend on the presence of at least two extracellular proteins: 
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mature brain-derived neurotrophic factor (mBDNF) and tissue-type plasminogen activator (tPA) 
(Michel et al., 2006 & Mou et al., 2009). 
tPA is a serine protease that converts inactive plasminogen into plasmin. It is most 
commonly known for its role in intravascular thrombolysis; however, studies have shown it is 
also an important part of the process of long-term potentiation in the hippocampus (Huang, Y. et 
al., 1996 & Sonderegger, P. et al., 2014). Plasmin, a downstream protease, cleaves the “pro” 
domain off of inactive proBDNF and converts it to its active form, mBDNF. The activated 
growth factor then binds to the tyrosine kinase-B (TRK-B) receptor on the post-synaptic 
membrane which, in conjunction with glutamate, initiates a phosphorylation cascade involving 
multiple kinases that eventually activate clock gene transcription. It is known that BDNF is 
rhythmically present in the SCN with higher levels at night than during the day (Liang et al., 
1998). In addition, tPA has also been shown to be rhythmically present in the SCN with higher 
levels during the night (Mou et al., 2009 & Panda et al., 2002). Although studies have shown 
these proteins are rhythmic in the SCN, the details of their subcellular localizations, which could 




Figure 1. Glutamate from the retinohypothalamic tract activates NMDA receptors in the SCN 
every time light is detected; however, phase shifts can only occur when mBDNF can 
concurrently activate the Trk B receptor. PAI
plasmin which converts pro-BDNF into m
 
Another influential protein is p
the activity of tPA by binding to its catalytically active 
means that the presence of PAI
However, PAI-1 requires binding to another
inhibit glutamate induced phase shifting. 
the extracellular matrix (ECM)
extracellularly in proximity to the ECM
different time points during the circ
regulation of its activation or inactivation to influence phase shifting.
The purpose of this project is to 
inhibitor, PAI-1, at different time points
immortalized cell culture of rat neurons from the SCN 2.2 line (
al., 2002). Use of the cell culture allows 
-1 inhibits tPA which activates plasminogen into 
-BDNF. 
 
lasminogen activator inhibitor-1 (PAI-1
small chain (Vehar et al., 1984).
-1 indirectly inhibits the activation of proBDNF
 protein, vitronectin, in order to remain 
Vitronectin is usually present in the fibrous
, which suggests that PAI-1 regulation of tPA likely occurs 
 (Preissner, K.T., 1991). Knowing the location of tPA at 
adian rhythm could enhance our understanding of the 
 
determine the subcellular localization of tPA and its 
 in the circadian rhythm over a 36-hour period using an 
Earnest et al., 1999 & Hurst et 
us to determine whether the proteins of interest are
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), which inhibits 
 This 
 to mBDNF. 
active and 




within or associated with the cells versus attached to the ECM versus floating in the extracellular 
space. The cell culture is preferable to testing mouse SCN brain slices because there is no 
reliable technique for separating the three different compartments using brain slices. 
 
METHODS AND MATERIALS 
 Immortalized SCN 2.2 cells were cultured and separated into three separate populations. 
Each received a different treatment: one cohort was synchronized with fetal bovine serum (FBS), 
another was synchronized with forskolin, and the third was given the control vehicle (Balsalobre, 
1998 & Yagita et al., 2000). FBS synchronizes the eukaryotic cell culture because it contains 
growth hormones to stimulate cell development (Franke, 2014). Forskolin activates adenylate 
cyclase which resets the cell cycle and synchronizes all the cells to circadian time 10 (CT 10). 
Circadian time 0-12 represents subjective day and CT 12-24 represents subjective night 
 For the first 36 hours immediately following treatment, samples were collected of the 
media, cells, and ECM every three hours from each of the three cohorts. These were stored at      
-80
o
C until protein assays could be completed. Two 36 hour time course experiments were 
performed, one in June another in October of 2013. 
Proteins were extracted from each of the three synchronization treatments of cell fraction 
samples using trichloroacetic acid (TCA). In future experiments, proteins from the ECM fraction 
will also be precipitated using TCA while proteins from the media fraction will be extracted 
using ammonium (Link et al., 2009 & Nair, 1973).  
Proteins from each of the 12 time points plus positive controls for tPA and PAI-1 were 
loaded into 10% acrylamide SDS-PAGE gels and separated based on molecular weight using 
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electrophoresis. Proteins in the gel were transferred to a polyvinylidene fluoride (PVDF) 
membrane and washed in 1xPBST phosphate buffered saline with 20% Tween. 
Proteins were visualized with immunoblotting. Prior to primary antibody application, a 
5% milk/1xPBST solution was applied to the blot for one hour to block non-specific binding of 
primary antibodies to non-target proteins on the membrane. The blot was exposed to primary 
antibodies in 2% milk/1xPBST and incubated overnight at 4
o
C. The following day, secondary 
antibodies were applied to the membrane for 90 minutes after 3x5 min washes in 1xPBST 
according to the concentrations in Table 1. Chemiluminescent luminol/hydrogen peroxide was 
applied for 3-5 minutes onto the membrane. This solution reacts to the horseradish peroxidase 
conjugated to the secondary antibody to produce microscopic light radiation. After luminol 
treatment, the blot was exposed to x-ray film for various periods from 5 seconds to 30 minutes. 
The fixed and developed film was scanned into the computer and analyzed with ImageJ software 
from the NIH. The pixel density of each protein band was quantified with ImageJ. Then 
Microsoft Excel was used to calculate band comparisons. Pixel densities of tPA and PAI-1 were 
divided by the corresponding lanes of α-tubulin load control. Values were normalized to CT 13. 









[H27B6] ab28374 Abcam 
1:500 Mouse 1:1000 
PAI-1 
[H135] sc-8979 Santa Cruz 
1:500 Rabbit 1:4000 
α-tubulin (load control) 
[B-5-1-2] sc-23948 Santa Cruz 
1:500 Mouse 1:2000 
Table 1. Proteins of interest and respective antibodies used to visualize them. Secondary 






Preliminary results confirmed the presence of tPA and PAI
SCN 2.2 cells. The results also show potentially rhythmic expression in PAI
forskolin and serum synchronization. Conversely, preliminary results s
steadily from onset of serum synchronization instead of being expressed rhythmically.
Figure 2 shows that PAI
PAI-1’s potential rhythm begins
decrease until its lowest expression at early subjective day 
the beginning of subjective night
appear to increase rather than decrease. Therefore
is not fully clear from these data whether 
circadian in nature. The PAI-1 positive control
Figure 2. Relative abundance of PAI
course following forskolin treatment
the cell after forskolin synchronization.
 
-1 in the cell fraction of the 
how that tPA increases 
-1 appears to be rhythmically present inside the cell fraction. 
 with high levels during early subjective night 
(CT 1). PAI-1 peaks 
. However, during the second subjective night, PAI
, although expression appears to be rhythmic, 
the rhythm in intracellular PAI
 did not develop with immunochemiluminescence.
-1 inside the cell is shown throughout the 36





(CT 13) that 
again just before 
-1 levels 
it 






The results from the FBS synchronized cells (
those from the forskolin synchronization. 
however, the PAI-1 positive control has a different 
the SCN due to possible glycosylation
throughout the first subjective night
during the second subjective night.
which shows a higher expression level
discarded as an outlier because it was 
 
Figure 3. Relative abundance of PAI
course after serum shock. There may be a possible rhythm in PAI
after FBS synchronization that mostly accords with
 
 
Figure 3) are somewhat
PAI-1 positive control confirms presence of PAI
molecular weight than the PAI
. PAI-1 expression in the SCN 2.2 cells again
, increases during the subjective day, and finally
 This overall pattern is disrupted only by the data from 
 than expected. (The data for the second CT 22
of 5.9 times higher than the 1
st
 data point at
-1 inside the cell is shown throughout the 36
-1 expression 
 forskolin experiment. n=1 
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-1; 





 CT 13). 
 
-hour time 
inside the cell 
 
In contrast to the two synchronized cohorts, the p
synchronized cells shown in Figure 4 
was expected because a synchroni
expression of those related to the circadian pacemaker
time point was omitted because it was 4.7 times higher than the density of PAI
Figure 4. Relative abundance of PAI
course after treatment with the 








indicate an arrhythmic pattern of PAI-1 
zing treatment is necessary to see a rhythm in protein 
 (Balsalobre et al., 1998).
-1 at CT 13.
-1 inside the cell is shown throughout the 36
vehicle control. There does not appear to be any noticeable 









Figure 5 shows the pattern of 
synchronization. There appears to be a
tPA positive control is clearly visible.
time point was much higher than 
 
Figure 5. Relative abundance of tPA inside the cell 




These preliminary results 
present inside the cell fraction of
intracellular PAI-1 levels may peak 
tPA expression in the SCN 2.2 cells following FBS
 steady increase throughout the 36 hour experiment.
 As in the two previous experiments, the data from 
the other data points by a factor of 29.5 so it was omitted
is shown throughout the 36
time; however, no circadian rhythms are apparent. n=1
(n=1 for each experiment) show that both tPA and PAI
 SCN2.2 cells throughout the circadian cycle. While speculative













has shown that total PAI-1 expression in brain slices, which includes all three subcellular 
compartments, similarly peaks during the early night (Mou, 2010). Whether this rhythm is 
actually in phase with the circadian clock will need to be determined by repeating each of these 
experiments.  
According to our model, PAI-1 inhibition should be greater during the subjective day 
than during the subjective night. One mechanism through which this could occur would be if 
extracellular PAI-1 levels are higher during the day than the night. Thus, higher intracellular 
PAI-1 levels during the subjective night as tentatively shown here could be consistent with less 
PAI-1 inhibition at night due to PAI-1 movement into the cell. However, it will be important to 
determine the level of PAI-1 in the extracellular media and associated with the ECM to 
determine whether this model is correct.  
Western blot analysis for tPA shows an increase in intracellular tPA expression 
throughout the 36 hour time course. This is not consistent with our model for the activation of 
BDNF to gate photic phase shifting, and it is different from the pattern of expression our lab has 
observed previously (Mou et al., 2009). Additional replicates may confirm this unexpected 
expression pattern or show results that support previous data. However, it is possible that the 
synchronization treatment decreases tPA to unnaturally low levels before it slowly increases to 
acclimate to its new synchronization environment. This experiment should be repeated using 
different synchronization techniques to see a clearer picture of the expression and localization of 
tPA. 
Several challenges arose with this project. One involved the need to use variable 
secondary antibody concentrations due to the low amount of protein in each lane of the 
acrylamide gel. Sonication was added to the TCA protein precipitation technique, and this 
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allowed the protein pellet to be broken up into much smaller fragments for better 
homogenization into the loading dye to be injected into the gel. This allowed us to use lower and 
more consistent secondary antibody concentrations, which led to less non-specific binding. The 
developed Western blots showed cleaner protein bands that were easier to analyze without nearly 
as much background noise. This method improved the results for PAI-1 and α-tubulin, but tPA 
still did not develop without excess background. In addition, both tPA and PAI-1 positive 
controls were inconsistently present for the last few Western blots. 
For analysis of potential circadian rhythms in protein expression, it is important to note 
that the free-running period for SCN 2.2 cells is not exactly 24 hours but has been shown to be 
closer to 22.5 hours (Balsalobre, 1998). This means that circadian time should be calculated 
using an 11.25 hour day: 11.25 hour night rhythm instead of a 12 hour day: 12 hour night 
rhythm. Although these results are graphed using a 24 hour cycle to be consistent with previous 
experiments in our lab, measuring the length of daytime and nighttime with the shorter period 
might be more appropriate in future studies. 
Moving forward, we must conduct further experiments investigating PAI-1 and tPA in 
the cell fraction of both 36 hour time courses. Next, the ECM and media fractions should be 
studied to draw more conclusions about the temporal localization of tPA and PAI-1 in different 
compartments. In the future, the cell culture time course could be extended to 48 hours because 
SCN 2.2 cells can maintain circadian rhythms for up to three days past synchronization 
(Balsalobre, 1998). This would allow us to improve the quality and accuracy of protein 
measurements by having multiple replicates of the same circadian time. In addition, allowing the 
cell culture at least 24 hours prior to initiating sampling could eliminate acute responses to the 
treatments by allowing the cells to acclimate to the synchronization treatments. This is because it 
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has been shown that certain clock genes have poor rhythmicity for 12-24 hours post 
synchronization (Ramsey, 2014). 
With more information on how the tPA proteolytic pathway affects the ability of the 
clock to shift phase, we can answer questions that could lead to future drug discoveries to help 
people with shift workers’ disorder, Alzheimer’s disease, jet lag, insomnia, metabolic disorders, 
and obesity related to the SCN’s function as the master pacemaker (Taniyama et al., 2015, 
Landry, 2014, & Eckel-Mahan, 2013). Moreover, tPA’s temporal location in the SCN and how it 
relates to gating circadian clock phase resetting may yield a greater understanding of the 
mechanisms behind the overarching phenomenon of metaplasticity. This is defined as the ability 
for one stimulus to cause a permanent or semi-permanent change in synapses that allows or 
prevents them from reacting to future stimuli (Abraham, 2008). This is relevant to other parts of 
the brain such as the hippocampus, where there is evidence that metaplasticity describes the 
function of gating whether the brain retains or forgets recent memories (Bramham et al., 2005, 
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